Neuphoria Therapeutics (NEUP) Leases (2021 - 2025)
Neuphoria Therapeutics (NEUP) reported Leases of $75219.0 for Q3 2025, down 61.9% year-over-year from $197447.0 in Q3 2024, and down 26.7% on a QoQ basis from $102612.0 in Q2 2025.
Neuphoria Therapeutics (NEUP) has 4 years of Leases data on file, last reported at $75219.0 in Q3 2025.
- Quarterly Leases fell 61.9% year-over-year to $75219.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $75219.0 (down 61.9% YoY) and the FY2025 annual result came in at $102612.0, down 52.71% from the prior year.
- Leases declined to $75219.0 in Q3 2025 per NEUP's latest filing, from $102612.0 in the prior quarter.
- Across five years, Leases topped out at $664338.9 in Q2 2021 and bottomed at $75219.0 in Q3 2025.
- The 4-year median for Leases is $197447.0 (2024), against an average of $268075.6.
- The widest annual swing landed in 2024, when Leases slumped 34.35%; it then tumbled 61.9% in 2025.
- Tracing NEUP's Leases over 4 years: stood at $549878.2 in 2021, then plunged by 39.9% to $330478.0 in 2023, then slumped by 54.45% to $150519.0 in 2024, then sank by 50.03% to $75219.0 in 2025.
- Per Business Quant, the three latest NEUP Leases figures stand at $75219.0 (Q3 2025), $102612.0 (Q2 2025), and $125213.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Neuphoria Therapeutics | 28.35 Mn | 8.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 75,219.00 |
| Jun 30, 2025 | 102,612.00 |
| Mar 31, 2025 | 125,213.00 |
| Dec 31, 2024 | 150,519.00 |
| Sep 30, 2024 | 197,447.00 |
| Jun 30, 2024 | 216,975.00 |
| Jun 30, 2023 | 330,478.00 |
| Dec 31, 2021 | 549,878.18 |
| Jun 30, 2021 | 664,338.89 |